Towards Healthcare
U.S. Genotyping Market Report by 2033 | Companies

U.S. Genotyping Market Size to Hit USD 23.33 Bn by 2033

The report covers U.S. Genotyping Market Analysis segmented by product such as instruments, reagents and kits, and software and services. Technology covers PCR, capillary electrophoresis, microarrays, sequencing, mass spectrometry and other methods. By Applications examines pharmacogenomics, diagnostics and personalized medicine, agricultural biotechnology, animal genetics and other areas. End-use considers pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes and others. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

U.S. Genotyping Market Assessment

  • Overview
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Instruments
    • Reagents & Kits
    • Software and Services
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • PCR
    • Capillary Electrophoresis
    • Microarrays
    • Sequencing
    • Mass Spectrometry
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Pharmacogenomics
    • Diagnostics and Personalized Medicine
    • Agricultural Biotechnology
    • Animal Genetics
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Pharmaceutical and Biopharmaceutical Companies
    • Diagnostics and Research Laboratories
    • Academic Institutes
    • Others

Company Profiles

  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GE Healthcare Inc.
  • Eurofins Scientific Inc.
  • Agilent Technologies
  • Danaher Corporation
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.

Conclusion & Recommendations

  • Insight Code: 5160
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

There are three types of genotypes: homozygous dominant (PP), homozygous recessive (pp) and heterozygous (Pp).

Genetic testing of skin, hair, blood, amniotic fluid or other tissues is used for the detection of genotypes.

Molecular beacons, DNA sequencing, SNP microarrays, mass spectrometry and PCR-based methods.

National Institute of Environmental Health Sciences, Centers for Disease Control and Prevention, American Society of Hematology, National Cancer Institute and National Institute of Health.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515